Search Results - "Ferreira Branquinho, D"

  • Showing 1 - 2 results of 2
Refine Results
  1. 1
    P602 Achievement of stringent histologic and composite endpoints in subjects with moderately to severely active ulcerative colitis treated with etrasimod: a post hoc analysis of the phase 3 ELEVATE UC 52 and ELEVATE UC 12 trials

    P602 Achievement of stringent histologic and composite endpoints in subjects with moderately to severely active ulcerative colitis treated with etrasimod: a post hoc analysis of the phase 3 ELEVATE UC 52 and ELEVATE UC 12 trials by Magro, F, Peyrin-Biroulet, L, Sands, B E, Danese, S, Jairath, V, Goetsch, M, Bhattacharjee, A, Wu, J, Ferreira Branquinho, D, Modesto, I, Feagan, B G

    Published in Journal of Crohn's and colitis (30-01-2023)
    Get full text
    Journal Article
    Save to List
    Saved in:
  2. 2
    P558 Etrasimod for the treatment of ulcerative colitis: analysis of infection rates from the phase 3 ELEVATE UC 52 and ELEVATE UC 12 clinical trials

    P558 Etrasimod for the treatment of ulcerative colitis: analysis of infection rates from the phase 3 ELEVATE UC 52 and ELEVATE UC 12 clinical trials by Regueiro, M, Siegmund, B, Yarur, A, Steinwurz, F, Gecse, K B, Goetsch, M, Bhattacharjee, A, Wu, J, Green, J, McDonnell, A, Crosby, C, Lazin, K, Ferreira Branquinho, D, Modesto, I, Abreu, M T

    Published in Journal of Crohn's and colitis (30-01-2023)
    Get full text
    Journal Article
    Save to List
    Saved in:

Search Tools: